SATB2 and neuroendocrine carcinoma: Low or absent SATB2 expression has been documented in the mucinous, micropapillary, medullary, and signet-ring CRC subtypes, and also in colorectal mixed adenoneuroendocrine carcinomas/neuroendocrine carcinomas (MANECs/NECs) [32,40].